National Beverage: Transforming Cellulite Awareness with Tiger Aesthetics' Innovative Avéli® Treatment
- National Cellulite Day highlights misconceptions; 90% of women affected but only 7% know actual cellulite causes.
- Tiger Aesthetics offers Avéli®, the first FDA-cleared treatment targeting cellulite's underlying causes with lasting results.
- Avéli® empowers women with effective solutions, promoting body positivity and informed choices regarding cellulite treatment.

Revolutionizing Cellulite Treatment: National Cellulite Day Sparks Awareness
In a recent survey conducted by Tiger Aesthetics on National Cellulite Day, significant misconceptions surrounding cellulite are brought to light. The survey reveals that up to 90% of women are affected by this skin condition, yet only 7% recognize its actual causes, which are primarily anatomical rather than linked to diet or exercise. This gap in understanding highlights the urgent need for education and awareness regarding cellulite, which many women still believe can be effectively treated with creams and gadgets despite the $3 billion spent annually on such products. The findings reflect a critical disconnect between consumer beliefs and the realities of cellulite treatment.
Tiger Aesthetics aims to address these misconceptions with its innovative Avéli® treatment, the first FDA-cleared, minimally invasive procedure specifically designed to tackle the underlying causes of cellulite. This groundbreaking treatment identifies and releases the fibrous bands that contribute to the dimpled appearance of skin, particularly on the thighs and buttocks. Clinical studies showcase Avéli®'s effectiveness, with lasting results evident even 12 months post-treatment. The procedure takes about an hour to complete and is available in over 700 aesthetic practices nationwide, boasting an impressive 90% "worth it" rating on RealSelf. Caroline Van Hove, President of Tiger Aesthetics, emphasizes that this initiative is about empowering women to embrace their bodies and make informed decisions about their treatment options.
The survey's results underscore a broader cultural context where women often feel pressured by societal beauty standards. By encouraging open conversations about cellulite, Tiger Aesthetics seeks to foster a supportive environment for women to discuss their experiences and explore effective solutions. The award-winning Avéli® treatment, recognized for two consecutive years as the "Best Minimally Invasive Cellulite Treatment" by NewBeauty, represents a significant advancement in addressing these concerns. As the company continues to educate and inform, it positions itself at the forefront of the aesthetic industry, dedicated to delivering real solutions for women facing the challenges of cellulite.
In addition to the survey results, the emphasis on education is particularly pertinent as many women remain unaware of the treatment options available to them. Rather than succumbing to ineffective remedies, the focus now shifts toward empowering women with the knowledge necessary to make informed choices. This commitment to education and awareness aligns with the broader mission of enhancing women's confidence and body positivity, paving the way for more constructive discussions around body image and self-acceptance.
Ultimately, the initiatives led by Tiger Aesthetics during National Cellulite Day serve as a catalyst for change in how cellulite is perceived and treated. With the introduction of Avéli®, women now have access to a proven method that not only alleviates the physical aspects of cellulite but also addresses the emotional and psychological impacts associated with it. As the conversation continues, Tiger Aesthetics stands ready to support women on their journey to self-empowerment and confidence.